Featured Research

from universities, journals, and other organizations

Driving To Work Increases Risk Of Heart Attack, Swedish Study Finds

Date:
May 12, 2009
Source:
The Swedish Research Council
Summary:
People who drive to work run a considerably greater risk of having a heart attack than those who are physically active on the way to work.

People who drive to work run a considerably greater risk of having a heart attack than those who are physically active on the way to work. This is shown in a new dissertation by Patrik Wennberg at Umeε University in Sweden.

Patrik Wennberg’s studies elucidate how various types of physical activity influence the risk of heart attack. Those who regularly drive to work run a 70 percent greater risk compared with those who walk, bike, or take the bus to work. The positive effect on weight and blood fats and the beneficial effects on propensity to experience blood clots and inflammation seems to be able to explain a substantial part, 40 percent of the reduced risk among those who are physically active on the way to work. 

High levels of recreational physical activity also lead to a lower risk of having a heart attack. High levels of physical activity at work also entail a lower risk of heart attack, but only in men.

The dissertation shows that those who use snuff but have never smoked do not run a greater risk of having a heart attack than those who do not use tobacco at all. Age, male gender, high blood pressure, smoking, diabetes, high blood fats, and excess weight are known risk factors for cardiovascular disease. The studies show that blood levels of markers for susceptibility to blood clots and inflammation are associated with increased risk of heart attack. Adding eight such markers enhances our ability to predict who will be affected.


Story Source:

The above story is based on materials provided by The Swedish Research Council. Note: Materials may be edited for content and length.


Cite This Page:

The Swedish Research Council. "Driving To Work Increases Risk Of Heart Attack, Swedish Study Finds." ScienceDaily. ScienceDaily, 12 May 2009. <www.sciencedaily.com/releases/2009/05/090511181358.htm>.
The Swedish Research Council. (2009, May 12). Driving To Work Increases Risk Of Heart Attack, Swedish Study Finds. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2009/05/090511181358.htm
The Swedish Research Council. "Driving To Work Increases Risk Of Heart Attack, Swedish Study Finds." ScienceDaily. www.sciencedaily.com/releases/2009/05/090511181358.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins